Malignant germ cell tumors (gcts) in the us

a 27-year perspective

Harriet O. Smith, Letitia B. Laming, Clifford R. Quails, Luis A. Padilla, Claire E. Verschracgcn

Research output: Contribution to journalArticle

Abstract

Objective: To evaluate population-based trends in incidence and survival for women with malignant GCTs (1973-1999). Methods: The SEER database was used to calculate overall and 5-year incidence rates (AAIRs) and survival by age at diagnosis, race, stage, and histology. Frequency distributions were compared using Fishers exact tests, and trends using the Jonckheere-Terpstra lest. Results: A total of 1,119 cases were identified, 1098 (98.1%) ovarian in origin. The overall AAIR was 0.36/100,000 woman-years. By histology, 373 (33.3%) were dysgerminomas, 461 (41.2%) were teratomas (433 immature, 28 mature with malignant degeneration), and 285 (25.5%) were non-dysgerminomas (157 endodermal sinus, 51 embryonal carcinoma, 24 choriocarcinoma, 53 mixed). For dysterminomas, but not other cell types, the AAIRs significantly decreased over calendar time (P = 0.02). By race (white, black, others), others had higher AAIRs (0.32, 0.35, 0.41, P = 0.009). By race, whites and others had higher rates of dysgerminoma compared with blacks (P = 0.01). For localized and distant disease, AAIRs rates decreased by 33.9%, and 23.4%, respectively, but increased for regional disease by 154%, (3.71% /year, P = 0.001). The 5-year relative survival was 82.6%. Survival varied significantly by histology (dysgerminomas 93.2%, teratomas 83.4%, other non-dysgerminomas 68.1%), stage (localized 93.3%, regional 83.7%, distant 66.2%, unstaged 70.0%), and age (0-9 yrs 97.4% vs. 60+ yrs, 22.2%, P < 0.001), but not by race (whites 89.3%, blacks 77.7%, others 82.3%, P = 0.70). Over 27 years, the 5-year survival rates increased by 33%. Conclusions: Malignant GCT AAIRs have decreased for dysgerminomas, and for distant and unstaged disease, and overall survival has also dramatically improved (by 33%). Dysgerminomas have significantly higher survival rates compared to other cell types. Unlike epithelial ovarian cancers, these data indicate that advances in treatment strategies have significantly impacted outcome.

Original languageEnglish (US)
Pages (from-to)511-512
Number of pages2
JournalCancer Journal
Volume9
Issue number6
StatePublished - 1996
Externally publishedYes

Fingerprint

Germ Cell and Embryonal Neoplasms
Dysgerminoma
Incidence
Histology
Survival
Survival Rate
Teratoma
Embryonal Carcinoma
Choriocarcinoma
Databases
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Smith, H. O., Laming, L. B., Quails, C. R., Padilla, L. A., & Verschracgcn, C. E. (1996). Malignant germ cell tumors (gcts) in the us: a 27-year perspective. Cancer Journal, 9(6), 511-512.

Malignant germ cell tumors (gcts) in the us : a 27-year perspective. / Smith, Harriet O.; Laming, Letitia B.; Quails, Clifford R.; Padilla, Luis A.; Verschracgcn, Claire E.

In: Cancer Journal, Vol. 9, No. 6, 1996, p. 511-512.

Research output: Contribution to journalArticle

Smith, HO, Laming, LB, Quails, CR, Padilla, LA & Verschracgcn, CE 1996, 'Malignant germ cell tumors (gcts) in the us: a 27-year perspective', Cancer Journal, vol. 9, no. 6, pp. 511-512.
Smith HO, Laming LB, Quails CR, Padilla LA, Verschracgcn CE. Malignant germ cell tumors (gcts) in the us: a 27-year perspective. Cancer Journal. 1996;9(6):511-512.
Smith, Harriet O. ; Laming, Letitia B. ; Quails, Clifford R. ; Padilla, Luis A. ; Verschracgcn, Claire E. / Malignant germ cell tumors (gcts) in the us : a 27-year perspective. In: Cancer Journal. 1996 ; Vol. 9, No. 6. pp. 511-512.
@article{1706f191931143cfb37772993525561a,
title = "Malignant germ cell tumors (gcts) in the us: a 27-year perspective",
abstract = "Objective: To evaluate population-based trends in incidence and survival for women with malignant GCTs (1973-1999). Methods: The SEER database was used to calculate overall and 5-year incidence rates (AAIRs) and survival by age at diagnosis, race, stage, and histology. Frequency distributions were compared using Fishers exact tests, and trends using the Jonckheere-Terpstra lest. Results: A total of 1,119 cases were identified, 1098 (98.1{\%}) ovarian in origin. The overall AAIR was 0.36/100,000 woman-years. By histology, 373 (33.3{\%}) were dysgerminomas, 461 (41.2{\%}) were teratomas (433 immature, 28 mature with malignant degeneration), and 285 (25.5{\%}) were non-dysgerminomas (157 endodermal sinus, 51 embryonal carcinoma, 24 choriocarcinoma, 53 mixed). For dysterminomas, but not other cell types, the AAIRs significantly decreased over calendar time (P = 0.02). By race (white, black, others), others had higher AAIRs (0.32, 0.35, 0.41, P = 0.009). By race, whites and others had higher rates of dysgerminoma compared with blacks (P = 0.01). For localized and distant disease, AAIRs rates decreased by 33.9{\%}, and 23.4{\%}, respectively, but increased for regional disease by 154{\%}, (3.71{\%} /year, P = 0.001). The 5-year relative survival was 82.6{\%}. Survival varied significantly by histology (dysgerminomas 93.2{\%}, teratomas 83.4{\%}, other non-dysgerminomas 68.1{\%}), stage (localized 93.3{\%}, regional 83.7{\%}, distant 66.2{\%}, unstaged 70.0{\%}), and age (0-9 yrs 97.4{\%} vs. 60+ yrs, 22.2{\%}, P < 0.001), but not by race (whites 89.3{\%}, blacks 77.7{\%}, others 82.3{\%}, P = 0.70). Over 27 years, the 5-year survival rates increased by 33{\%}. Conclusions: Malignant GCT AAIRs have decreased for dysgerminomas, and for distant and unstaged disease, and overall survival has also dramatically improved (by 33{\%}). Dysgerminomas have significantly higher survival rates compared to other cell types. Unlike epithelial ovarian cancers, these data indicate that advances in treatment strategies have significantly impacted outcome.",
author = "Smith, {Harriet O.} and Laming, {Letitia B.} and Quails, {Clifford R.} and Padilla, {Luis A.} and Verschracgcn, {Claire E.}",
year = "1996",
language = "English (US)",
volume = "9",
pages = "511--512",
journal = "Cancer Journal from Scientific American",
issn = "1528-9117",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Malignant germ cell tumors (gcts) in the us

T2 - a 27-year perspective

AU - Smith, Harriet O.

AU - Laming, Letitia B.

AU - Quails, Clifford R.

AU - Padilla, Luis A.

AU - Verschracgcn, Claire E.

PY - 1996

Y1 - 1996

N2 - Objective: To evaluate population-based trends in incidence and survival for women with malignant GCTs (1973-1999). Methods: The SEER database was used to calculate overall and 5-year incidence rates (AAIRs) and survival by age at diagnosis, race, stage, and histology. Frequency distributions were compared using Fishers exact tests, and trends using the Jonckheere-Terpstra lest. Results: A total of 1,119 cases were identified, 1098 (98.1%) ovarian in origin. The overall AAIR was 0.36/100,000 woman-years. By histology, 373 (33.3%) were dysgerminomas, 461 (41.2%) were teratomas (433 immature, 28 mature with malignant degeneration), and 285 (25.5%) were non-dysgerminomas (157 endodermal sinus, 51 embryonal carcinoma, 24 choriocarcinoma, 53 mixed). For dysterminomas, but not other cell types, the AAIRs significantly decreased over calendar time (P = 0.02). By race (white, black, others), others had higher AAIRs (0.32, 0.35, 0.41, P = 0.009). By race, whites and others had higher rates of dysgerminoma compared with blacks (P = 0.01). For localized and distant disease, AAIRs rates decreased by 33.9%, and 23.4%, respectively, but increased for regional disease by 154%, (3.71% /year, P = 0.001). The 5-year relative survival was 82.6%. Survival varied significantly by histology (dysgerminomas 93.2%, teratomas 83.4%, other non-dysgerminomas 68.1%), stage (localized 93.3%, regional 83.7%, distant 66.2%, unstaged 70.0%), and age (0-9 yrs 97.4% vs. 60+ yrs, 22.2%, P < 0.001), but not by race (whites 89.3%, blacks 77.7%, others 82.3%, P = 0.70). Over 27 years, the 5-year survival rates increased by 33%. Conclusions: Malignant GCT AAIRs have decreased for dysgerminomas, and for distant and unstaged disease, and overall survival has also dramatically improved (by 33%). Dysgerminomas have significantly higher survival rates compared to other cell types. Unlike epithelial ovarian cancers, these data indicate that advances in treatment strategies have significantly impacted outcome.

AB - Objective: To evaluate population-based trends in incidence and survival for women with malignant GCTs (1973-1999). Methods: The SEER database was used to calculate overall and 5-year incidence rates (AAIRs) and survival by age at diagnosis, race, stage, and histology. Frequency distributions were compared using Fishers exact tests, and trends using the Jonckheere-Terpstra lest. Results: A total of 1,119 cases were identified, 1098 (98.1%) ovarian in origin. The overall AAIR was 0.36/100,000 woman-years. By histology, 373 (33.3%) were dysgerminomas, 461 (41.2%) were teratomas (433 immature, 28 mature with malignant degeneration), and 285 (25.5%) were non-dysgerminomas (157 endodermal sinus, 51 embryonal carcinoma, 24 choriocarcinoma, 53 mixed). For dysterminomas, but not other cell types, the AAIRs significantly decreased over calendar time (P = 0.02). By race (white, black, others), others had higher AAIRs (0.32, 0.35, 0.41, P = 0.009). By race, whites and others had higher rates of dysgerminoma compared with blacks (P = 0.01). For localized and distant disease, AAIRs rates decreased by 33.9%, and 23.4%, respectively, but increased for regional disease by 154%, (3.71% /year, P = 0.001). The 5-year relative survival was 82.6%. Survival varied significantly by histology (dysgerminomas 93.2%, teratomas 83.4%, other non-dysgerminomas 68.1%), stage (localized 93.3%, regional 83.7%, distant 66.2%, unstaged 70.0%), and age (0-9 yrs 97.4% vs. 60+ yrs, 22.2%, P < 0.001), but not by race (whites 89.3%, blacks 77.7%, others 82.3%, P = 0.70). Over 27 years, the 5-year survival rates increased by 33%. Conclusions: Malignant GCT AAIRs have decreased for dysgerminomas, and for distant and unstaged disease, and overall survival has also dramatically improved (by 33%). Dysgerminomas have significantly higher survival rates compared to other cell types. Unlike epithelial ovarian cancers, these data indicate that advances in treatment strategies have significantly impacted outcome.

UR - http://www.scopus.com/inward/record.url?scp=33749567163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749567163&partnerID=8YFLogxK

M3 - Article

VL - 9

SP - 511

EP - 512

JO - Cancer Journal from Scientific American

JF - Cancer Journal from Scientific American

SN - 1528-9117

IS - 6

ER -